Theralase Technologies Inc. (TLT) — Capital Reinvestment Ratio
Latest as of September 2018:
0.05x
Theralase Technologies Inc. (TLT) has a Capital Reinvestment Ratio of 0.05x as of September 2018, meaning it reinvests 0% of its operating cash flow (CA$436.21K) in capital expenditures (CA$19.98K). See Theralase Technologies Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
CA$436.21K
CAD
Capital Expenditures
CA$19.98K
CAD
Data as of
Sep 2018
Most recent filing
Theralase Technologies Inc. Capital Reinvestment Ratio (2005–2005)
This chart tracks Theralase Technologies Inc.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Theralase Technologies Inc. (2005–2005)
Year-by-year Capital Reinvestment Ratio for Theralase Technologies Inc. from 2005 to 2005. For live market cap and broader valuation context, see how much is Theralase Technologies Inc. worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2005 | 1.00x | CA$85.33K | CA$85.30K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow